Barclays »

Denali Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2023-12-31 $7.9M 369k 21.46
2023-09-30 $3.4M 167k 20.63
2023-06-30 $4.7M 159k 29.51
2023-03-31 $15M 656k 23.04
2022-12-31 $16M 586k 27.81
2022-09-30 $10M 326k 30.69
2022-06-30 $11M 369k 29.43
2022-03-31 $1.9M 58k 32.17
2021-12-31 $5.4M 121k 44.59
2021-09-30 $3.6M 71k 50.45
2021-06-30 $1.9M 24k 78.48
2021-03-31 $5.1M 90k 57.09
2020-12-31 $1.9M 23k 83.79
2020-09-30 $1.0M 29k 35.85
2020-06-30 $860k 36k 24.16
2020-03-31 $314k 18k 17.49
2019-12-31 $848k 49k 17.42
2019-09-30 $681k 45k 15.32
2019-06-30 $642k 31k 20.77
2019-03-31 $319k 14k 23.22
2018-09-30 $371k 17k 21.73
2018-06-30 $19k 1.2k 15.35
2018-03-31 $65k 3.3k 19.48